Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging

Mya S. Thu, L. Henry Bryant, Tiziana Coppola, E. Kay Jordan, Matthew D. Budde, Bobbi K. Lewis, Aneeka Chaudhry, Jiaqiang Ren, Nadimpalli Ravi S. Varma, Ali S. Arbab, Joseph A. Frank

Research output: Contribution to journalArticlepeer-review

137 Scopus citations

Abstract

We report on a new straightforward magnetic cell-labeling approach that combines three US Food and Drug Administration (FDA)-approved drugs - ferumoxytol, heparin and protamine - in serum-free medium to form self-assembling nanocomplexes that effectively label cells for in vivo magnetic resonance imaging (MRI). We observed that the ferumoxytol-heparin-protamine (HPF) nanocomplexes were stable in serum-free cell culture medium. HPF nanocomplexes show a threefold increase in T2 relaxivity compared to ferumoxytol. Electron microscopy showed internalized HPF in endosomes, which we confirmed by Prussian blue staining of labeled cells. There was no long-term effect or toxicity on cellular physiology or function of HPF-labeled hematopoietic stem cells, bone marrow stromal cells, neural stem cells or T cells when compared to controls. In vivo MRI detected 1,000 HPF-labeled cells implanted in rat brains. This HPF labeling method should facilitate the monitoring by MRI of infused or implanted cells in clinical trials.

Original languageEnglish (US)
Pages (from-to)463-467
Number of pages5
JournalNature Medicine
Volume18
Issue number3
DOIs
StatePublished - Mar 2012

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging'. Together they form a unique fingerprint.

Cite this